The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis:

BackgroundIn chronic diseases such as multiple sclerosis requiring lifelong treatment, studies on long-term outcomes are important.ObjectiveTo assess disability and magnetic resonance imaging-relat...